Chamber, Other Biz Groups Back Insulin Cos. At High Court

By Bryan Koenig · April 13, 2026, 6:04 PM EDT

The U.S. Chamber of Commerce and other business groups urged the U.S. Supreme Court to take up an appeal from Sanofi-Aventis, Eli Lilly, Novo Nordisk and AstraZeneca, arguing the Second Circuit's...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Mosaic Health, Inc. v. Sanofi?Aventis U.S., LLC

Case Number

Court

Appellate - 2nd Circuit

Nature of Suit

Date Filed

March 04, 2024

Case Title

AstraZeneca Pharmaceuticals LP, et al., Petitioners v. Mosaic Health, Inc., et al.

Case Number

Court

Supreme Court

Nature of Suit

Date Filed

March 11, 2026

Recent Articles By Bryan

April 13, 2026
Mylan Can't Revive Copaxone Antitrust Claims Against Teva
April 09, 2026
Nonprofit Insurer Wants To Seek AstraZeneca Claims Revival
March 31, 2026
Anesthesia Parent Can't Duck Antitrust Suit, But Affiliate Can
March 10, 2026
Sanofi Says Judge Botched Insulin Device Patent Listings
March 10, 2026
CVS Can't 'Relitigate' Price-Gouging Class Cert.
March 06, 2026
Actelion Pays $65M To Settle Tracleer Antitrust Class Suit
March 05, 2026
9th Circ. Denies Bail Pending Nurse Wage-Fixing Appeal
March 03, 2026
FTC Makes 'Significant Progress' In OptumRx, Caremark Talks
February 11, 2026
Luxottica Franchisee Gets Another Shot At Antitrust Claims
February 04, 2026
Express Scripts Makes 'Fundamental Changes' In FTC Deal